Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
112 USD | -9.27% | -13.11% | +16.35% |
05:09pm | Sarepta Therapeutics Shares Fall After RBC Downgrade | MT |
12:44pm | RBC Downgrades Sarepta Therapeutics to Sector Perform From Outperform, Lowers Price Target to $142 From $157 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.35% | 11.67B | |
+9.80% | 118B | |
+10.10% | 106B | |
-11.49% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.61% | 15.97B | |
+6.51% | 14.03B | |
-32.15% | 7.55B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- UBS Adjusts Price Target on Sarepta Therapeutics to $173 From $167, Maintains Buy Rating